DNASequence is pleased to announce a collaboration with the Athens Naval Hospital, in a pilot metagenomic study for the analysis of clinical samples from Intensive Care Units (ICUs) patients.

This study is carried out for the first time in Greece and aims to detect pathogens and antimicrobial resistance genes with high accuracy, as well as to evaluate the laboratory and bioinformatic protocols dedicated to clinical samples.

This study is also part of the effort of DNASequence to expand its services in human clinical samples.
DNASequence, with the support of Motor Oil Hellas, completed a biosafety monitoring project inside the premises of the Athens Naval Hospital, with a direction for optimization of cleaning & biosafety protocols. The project aimed to detect microorganisms on various surfaces of the hospital, as well as antibiotic resistance genes, with the ultimate goal of reducing hospital-acquired infections in the future wing of the NNA sponsored by Motor Oil.
For the first time in Greece, Metagenomics analysis will be applied for the purpose of nosocomial infection mapping.

The project will be realized in collaboration with the School of Medicine of UOA and specifically with the laboratory of Prof. Dr. Lagiou and Assistant Prof. Dr. Magiorkinis.

We would like to thank Prof. Dr. Kotanidou, i.e. the project lead, for the trust and collaboration, as well as the President of the UOA School of Medicine Prof. Dr. Gerasimos Siasos